Time-course study of the protection induced by an interferon-inducible DNA vaccine against viral haemorrhagic septicaemia in rainbow trout. Fish and Shellfish Immunology, 85, 99-105. ABSTRACT 21 The highly effective DNA vaccines against diseases caused by fish rhabdoviruses in farmed fish 22 consist of a DNA plasmid vector encoding the viral glycoprotein under the control of a 23 constitutive cytomegalovirus promoter (CMV). Among others, attempts to improve efficacy and 24 safety of these DNA vaccines have focused on regulatory elements of plasmid vectors, which 25 play a major role in controlling expression levels of vaccine antigens. Depending on the 65 lasts for a few weeks. It is characterized by up-regulating the expression of 66 interferon type I (IFN I), and consequently also increased transcription of multiple 67 interferon-stimulated genes (ISG) [11-15].
35
The in vitro analysis showed that while the DNA vaccine with the CMV promoter constitutively 36 drove the expression of EGFP in both fish and human cell lines, the DNA vaccine with the Mx 37 promoter inducibly enhanced the expression of EGFP in the fish cell line.
38
To address the impact on protection, a time-course model was followed as suggested by 39 Kurath et al. (2006) , where vaccinated fish were challenged with VHSV at 2, 8 and 78 weeks 40 post-vaccination (wpv). The DNA vaccine with the CMV promoter protected at all times, while 41 vaccination with the DNA vaccine containing the Mx promoter only protected the fish at 8 wpv.
42
However, following induction with Poly(I:C) one week before the challenge, high protection 43 was also evident at 2 wpv.
44
In conclusion, the results revealed a more fish host dependent activity of the trout Mx 
(i)
The early antiviral response (EAVR), which comprise cross-reactive protection 63 associated with innate antiviral immune mechanisms. This protective phase starts 64 shortly (within days) after the intramuscular injection of the DNA vaccine but only
The long-term antiviral response (LAVR), which follows the SAVR, is characterized 73 by slightly lower protection than in SAVR and minimal levels or absence of 74 neutralizing antibodies in fish which have not been exposed to virus. This phase like 75 the SAVR, is thought to be associated with specific adaptive immune mechanisms,
76
although this remains to be demonstrated [10, 18] .
77
Considering that the persistence of a plasmid in fish tissue could last up to 535 days after 
248
while the CMV-plasmids without the G gene did not induce any protection against VHS (Fig. 4 ).
249
The vaccine encoding the IHNV G protein only was able to induce protection against VHS 283 (Table 4 ). On average, the fish immunized with pcDNA3-Mx-vhsG showed a lower cumulative M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
15 mortality than the group given plasmid without insert, but this difference was not significant. A
285
relatively high variability in mortality was evident between replicate aquaria in some of the 286 groups, possibly reflecting that immersion challenge of relatively larger fish (50-70g) is more 287 sensitive to small tank variations compared to challenge trials with small (3-10g) fish. (Fig. 5 ). 
288
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The protective effect at 78 wpv reported here for the pcDNA3-CMV-vhsG vaccinated fish along -Immunity to VHS induced by DNA vaccine with CMV promoter last more than 17 months.
-No direct link between early and specific protection following DNA vaccination.
